044 – Marker Therapeutics DISAPPOINTS in pancreatic cancer

Hi all, today I talk about the #MRKR interim update of their MultiTAA treatment in pancreatic cancer. I go through the data in all 3 arms and analyze whether or not they see an actual effect of their unique therapy.

*this is not investment advice*

#breaking biotech #biotech


039 – Will Marker Therapeutics Succeed in Pancreatic Cancer?

Hi everybody, in this episode I take a deeper dive into pancreatic cancer and how Marker Therapeutics’ MultiTAA T Cell therapy might fare against it.

Thanks for watching!

Follow me on twitter @matthewlepoire

Note: *This is not investment advice*

%d bloggers like this: